| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7630763 | Journal of Pharmaceutical and Biomedical Analysis | 2014 | 6 Pages |
Abstract
- Dabigatran and rivaroxaban are target specific oral anticoagulants (TSOACs).
- This is an analytical method to quantify simultaneously dabigatran and rivaroxaban in human plasma.
- Dabigatran and rivaroxaban are stable in plasma 1 month at 3 different conditions of temperature.
- It was successfully applied to 65 patient plasma samples.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Marie Korostelev, Kevin Bihan, Lison Ferreol, Nadine Tissot, Jean-Sebastien Hulot, Christian Funck-Brentano, Noël Zahr,